Cargando…
EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice
Obesity is often associated with increased risk of cardiovascular diseases. Previous studies suggest that epidermal growth factor receptor (EGFR) antagonism may be effective for the treatment of angiotensin II-induced cardiac hypertrophy and diabetic cardiomyopathy. This study was performed to demon...
Autores principales: | Li, Weixin, Fang, Qilu, Zhong, Peng, Chen, Lingfeng, Wang, Lintao, Zhang, Yali, Wang, Jun, Li, Xiaokun, Wang, Yi, Wang, Jingying, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263857/ https://www.ncbi.nlm.nih.gov/pubmed/27087279 http://dx.doi.org/10.1038/srep24580 |
Ejemplares similares
-
EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation
por: Fang, Qilu, et al.
Publicado: (2016) -
Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2
por: Wang, Yi, et al.
Publicado: (2017) -
Author Correction: Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2
por: Wang, Yi, et al.
Publicado: (2018) -
Blockade of myeloid differentiation protein 2 prevents obesity‐induced inflammation and nephropathy
por: Fang, Qilu, et al.
Publicado: (2017) -
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)